TC |
Stat |
Stk |
Ins |
Fil |
+d |
+w |
+m |
+q |
+h |
+y |
avg |
|---|---|---|---|---|---|---|---|---|---|---|---|
| S | %ret | 1 | 1 | 1 | 0 | -8 | -2 | -31 | -32 | 0 | -18 |
| S | %wins | 100 | 100 | 100 | 100 | 100 | 100 |
Filing Date |
T Date |
Ticker |
Issuer | Inc | Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
3/12/20 19:01 | 3/10/20 | NVIV | Invivo Therapeutics Holdings Corp. | NV | Health | MdEq | Surgical & Medical Instrument | Christopher Richard | MA | O | CFO,Trea | P.d | 0 | 0.00 | 0 | 4 | 230 | 5 | D | ||||||||||||||
11/13/12 14:05 | 11/13/12 | DUSA | Dusa Pharmaceuticals Inc | NJ | Health | Drug | Pharmaceutical Preparations | Christopher Richard | MA | O | VP Finan | M.d | 12 | 1.60 | 0 | 8 | 3 | 276 | D | ||||||||||||||
5/13/11 14:46 | 5/12/11 | DUSA | Dusa Pharmaceuticals Inc | NJ | Health | Drug | Pharmaceutical Preparations | Christopher Richard | MA | O | VP Finan | M.d | 65 | 1.53 | 3 | 43 | 39 | 151 | D | 328 | 183 | 130 | 98 | 15 | -1 | 24 | 3 | 0 | -8 | -2 | -31 | -32 | |
5/13/11 14:46 | 5/12/11 | DUSA | Dusa Pharmaceuticals Inc | NJ | Health | Drug | Pharmaceutical Preparations | Christopher Richard | MA | O | VP Finan | S.d | -253 | 5.94 | 3 | -43 | -22 | 151 | D | 328 | 183 | 130 | 98 | 15 | -1 | 24 | 3 | 0 | -8 | -2 | -31 | -32 |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |